jeremiah@devisedesigns.com, Author at Corcept Therapeutics

This author has not written his bio yet.
But we are proud to say that jeremiah@devisedesigns.com contributed 151 entries already.

Efficacy and Safety of the Selective Glucocorticoid Receptor Modulator, Relacorilant (up to 400 mg/day), in Patients With Endogenous Hypercortisolism

Pivonello et al. • 2019 • American Association of Clinical Endocrinologists (AACE) 28th Annual Scientific & Clinical Congress

August 3, 2020

• •

May 29, 2020

Koorneef et al. • 2018 • Endocrinology. 2018, 159(12):3925–3936

December 3, 2019

Belanoff et al. • 2010 • Diabetes Obes Metab. 2010;12(6):545-7.

December 2, 2019

Elhassan et al • 2019 • Ann Intern Med.

November 10, 2019

Atucha et al. • 2015 • Endocrinology. 2015;156(11):4105-4114.

October 25, 2018

Hunt et al. • 2017 • J Med Chem. 2017;60(8):3405-3421.

October 25, 2018

Clark et al. • 2008 • Bioorg Med Chem Lett. 2008;18(4):1312-7.

October 25, 2018

Hunt et al. • 2017 • Clin Pharmacol Drug Dev. 2017 Oct 2. doi: 10.1002/cpdd.389.

October 25, 2018

Bali et al. • 2016 • J Clin Endocrinol Metab. 2016;101(11):4305-4312.

October 25, 2018